Search results
Jump to navigation
Jump to search
- 2013年、インド最高裁はNovartisの抗がん剤である[[:en:Gleevec|Gleevec]]の最終製剤に関するNovartisのインドでの特許出願を[[:en:Novartis v. Union of India & Others|the |Gleevec/Glivec ([[Wikipedia:imatinib|imatinib]])||[[Wikipedia:Oncology|腫瘍(Oncology) ...62 KB (2,675 words) - 18:53, 2 January 2024
- [[Novartis]]は、インドにおける薬物[[Gleevec/ja|グリベック]]の特許をめぐってインド政府と長期にわたる争いを繰り広げ、[[:en:Novartis v. Union of India & Ot ...58 KB (1,845 words) - 17:09, 5 November 2023
- ...tle with the government of India over the patenting of its drug, [[Gleevec|Gleevec]], in India, which ended up in a Supreme Court in a case known as [[:en:Nov ...52 KB (6,923 words) - 17:09, 5 November 2023
- ...tle with the government of India over the patenting of its drug, [[Gleevec|Gleevec]], in India, which ended up in a Supreme Court in a case known as [[:en:Nov ...54 KB (7,245 words) - 17:08, 5 November 2023